Since its inception in 2016, the fund has achieved the following 
  • Over 48% of eligible Quad faculty applied
  • Reviewed 186 grant proposals
  • Q-FASTR awardees had 5 new start-up companies and close to $185 million in follow-on funding, which corresponds to 13.8 times our investment

2025 Request for Proposals

Release date: Friday, January 3, 2025

Pre-proposal due: Friday, January 31, 2025

Full proposal due: Wednesday, April 23, 2025

Funding start date: Tuesday, July 1, 2025

How to Apply

2024 Awardees

Congratulations to the following award recipients of the 2024 Q-FASTR RFP:

  • Karen Adelman (Harvard Medical School) and Zuzana Tothova (Dana-Farber Cancer Institute)
  • Stephen Blacklow (Harvard Medical School)
  • George Church (Harvard Medical School)
  • Sloan Devlin (Harvard Medical School)
  • Lucas Farnung (Harvard Medical School)
  • Timothy Mitchison (Harvard Medical School)
  • Peter Park (Harvard Medical School) and Doga Gulhan (Massachusetts General Hospital)
  • Norbert Perrimon (Harvard Medical School)
  • David Scadden (Harvard Medical School)
  • Pamela Silver (Harvard Medical School)
  • Amy Wagers (Harvard Medical School)

For more details about their research, please visit the Projects section.

Q-FASTR Projects
2023 Q-FASTR Poster Showcase & Reception

Q-FASTR is dedicated to transforming cutting-edge basic research at HMS into tomorrow’s therapeutics, diagnostics, and related technologies. By championing early ideas and enveloping them with financial and scientific support, we cultivate breakthroughs that have the potential to reshape medicine.

Ifat Rubin-Bejerano
Senior Director, Translational Research Programs, Harvard Medical School